BIIB | Biogen Inc. Analyst Estimates | MarketWatch Nov 09, 2019 · Biogen Inc. analyst estimates by MarketWatch. View BIIB revenue estimates and earnings estimates, as well as analyst recommendations. BIIB | Biogen Inc. Stock Price & News - WSJ View the latest Biogen Inc. (BIIB) stock price, news, historical charts, analyst ratings and financial information from WSJ. Dow Jones, a News Corp company. Biogen Inc. (BIIB) Stock Price, Quote, History & News ...
Real time Biogen (BIIB) stock price quote, stock graph, news & analysis.
BIIB Stock Price | Biogen Inc. Stock Quote (U.S.: Nasdaq ... BIIB | Complete Biogen Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. BIIB Stock Price, Forecast & News (Biogen) | MarketBeat Price Target Upside/Downside. According to analysts' consensus price target of $325.40, Biogen has a potential upside of 8.3% from its current price of $300.51. Amount of Analyst Coverage. Biogen has been the subject of 18 research reports in the past 90 days, demonstrating strong analyst interest in … Biogen Inc. Common Stock (BIIB) Analyst Research | Nasdaq Based on analysts offering 12 month price targets for BIIB in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00. Sign in to your Biogen Inc. (BIIB) Analyst Ratings, Estimates & Forecasts ...
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM to treat plaque psoriasis.
BIIB - Biogen Inc Stock quote - CNNMoney.com Find real-time BIIB - Biogen Inc stock quotes, company profile, news and forecasts from CNN Business. BIIB: Biogen Inc Price Target | I3investor Stock: BIIB, Avg Price Target: USD446.00. Average Target Price, Price Call and Upside/Downside are derived from Price Targets in the past 6 months. Biogen Alzheimer Drug Not a Done Deal as BIIB Stock Surges ...
BIIB | Complete Biogen Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (79.2%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - Biogen Inc. [BIIB] stock Initiated by Barclays analyst ... The new note on the price target was released on January 27, 2020, representing the official price target for Biogen Inc. stock. Previously, the target price had yet another raise from $260 to $300, while Credit Suisse kept a Neutral rating on BIIB stock. Biogen Inc. [BIIB] Price Analysis: NASDAQ:BIIB Bull Target ... Mar 19, 2020 · Biogen Inc. is said to have a 12-month price target set at $334.82. That means that the stock has a strong potential to acquire 36.14% increase from the current trading price. Biogen Inc. [NASDAQ:BIIB]: Analyst Rating and Earnings. This is compared to its latest closing price of $305.32. BIIB - Biogen Inc Stock quote - CNNMoney.com Find real-time BIIB - Biogen Inc stock quotes, company profile, news and forecasts from CNN Business.
In depth view into BIIB (Biogen) stock including the latest price, news, dividend history, earnings information and financials.
Detailed price information for Biogen Inc (BIIB-Q) from The Globe and Mail including charting Market movers: Stocks that saw action on Thursday - and why. BIIB stock rating and analysis - Biogen : a summary of key financial strength and profitability metrics. Price-to-Intrinsic-Value-DCF (Earnings Based), 0.34. BIIB Price Target and Analyst Ratings (Biogen) | MarketBeat Nov 09, 2019 · 31 Wall Street analysts have issued ratings and price targets for Biogen in the last 12 months. Their average twelve-month price target is $325.40, suggesting that the stock has a possible upside of 9.04%. The high price target for BIIB is $410.00 and the low price target for BIIB is $231.00. BIIB Stock Price | Biogen Inc. Stock Quote (U.S.: Nasdaq ...